Real-time enrollment status for this early alzheimer's disease clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06653153 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Early Alzheimer's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 1,400 participants |
| Active Locations | 123 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | November 20, 2025 (Nov 20, 2025) |
As of March 2, 2026: Clinical trial NCT06653153 is currently active_not_recruiting participants. This clinical trial study for early alzheimer's disease is not currently accepting new participants at 123 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06653153 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 123 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06653153 was last updated Nov 20, 2025 (November 20, 2025). HelloStudys verifies this status automatically.